Nothing Special   »   [go: up one dir, main page]

Villaverde, 2011 - Google Patents

Nanoparticles in translational science and medicine

Villaverde, 2011

Document ID
15001033191625509732
Author
Villaverde A
Publication year

External Links

Snippet

This volume explores some of the most exciting recent advances in basic research on nanoparticles in translational science and medicine and how this knowledge is leading to advances in the various fields.-This series provides a forum for discussion of new …
Continue reading at books.google.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48876—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being a solid micro- or nanoparticle having no hollow or gas-filled core
    • A61K47/48884—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being a solid micro- or nanoparticle having no hollow or gas-filled core the form being a nanoparticle, e.g. an immuno-nanoparticle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb

Similar Documents

Publication Publication Date Title
Villaverde Nanoparticles in translational science and medicine
Biondi et al. Nanoparticle-integrated hydrogels as multifunctional composite materials for biomedical applications
Štimac et al. Adamantane in drug delivery systems and surface recognition
Qiu et al. Enhanced delivery of therapeutic siRNA into glioblastoma cells using dendrimer-entrapped gold nanoparticles conjugated with β-cyclodextrin
Nieciecka et al. Hybrid system for local drug delivery and magnetic hyperthermia based on SPIONs loaded with doxorubicin and epirubicin
Kumar et al. Nanotechnology and Nanomaterials in the Treatment of Life-threatening Diseases
Jiang et al. Hyaluronic acid-decorated laponite® nanocomposites for targeted anticancer drug delivery
Kolovskaya et al. Aptamer-conjugated superparamagnetic ferroarabinogalactan nanoparticles for targeted magnetodynamic therapy of cancer
Li et al. Supramolecular polymer nanocomposites for biomedical applications
Liu et al. Dual targeting biomimetic liposomes for paclitaxel/DNA combination cancer treatment
Lee Molecular modeling of PEGylated peptides, dendrimers, and single-walled carbon nanotubes for biomedical applications
Ag Seleci et al. Transferrin-decorated niosomes with integrated InP/ZnS quantum dots and magnetic iron oxide nanoparticles: dual targeting and imaging of glioma
Sun et al. Phospholipid-coated mesoporous silica nanoparticles acting as lubricating drug nanocarriers
Zhang et al. Hyaluronic acid-chitosan nanoparticles to deliver Gd-DTPA for MR cancer imaging
Guo et al. Enhanced radiation therapy of gold nanoparticles in liver cancer
Li et al. pH-responsive drug delivery and imaging study of hybrid mesoporous silica nanoparticles
Nair et al. Cytochalasin B treatment and osmotic pressure enhance the production of extracellular vesicles (EVs) with improved drug loading capacity
Huang et al. Functionalized asymmetric bola-type amphiphiles for efficient gene and drug delivery
Joo et al. Shape effects of peptide amphiphile micelles for targeting monocytes
Martínez-Negro et al. A non-viral plasmid DNA delivery system consisting on a lysine-derived cationic lipid mixed with a fusogenic lipid
Zhu et al. Targeting pancreatic cancer cells with peptide-functionalized polymeric magnetic nanoparticles
Antunes et al. Trends in nanopharmaceutical patents
Popova et al. Tamoxifen delivery system based on PEGylated magnetic MCM-41 silica
Deng et al. Surface-functionalized NdVO4: Gd3+ nanoplates as active agents for near-infrared-light-triggered and multimodal-imaging-guided photothermal therapy
Ashrafuzzaman et al. Cell surface binding and lipid interactions behind chemotherapy-drug-induced ion pore formation in membranes